Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

sector : Professional, scientific, and technical services    crawled date : 2022 - 03 - 09    save search

E-Home Household Services Holdings Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Published: 2022-03-09 (Crawled : 23:00) - globenewswire.com
EJH | $2.91 -1.69% -1.72% 22K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: -1.18% H: 3.92% C: 1.2%

nasdaq services rice
Prometheus Biosciences Reports Fourth Quarter and Full-Year 2021 Financial Results and Highlights Recent Corporate Progress
Published: 2022-03-09 (Crawled : 22:00) - biospace.com/
RXDX | $199.92 0.02% 1.9M twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 2.08% H: 9.62% C: 8.89%

financial results report bioscience results
UpHealth Appoints Ashish Chona as EVP, Integrated Care
Published: 2022-03-09 (Crawled : 14:30) - prnewswire.com
UPH | $0.3 9.13% 0.0% 350K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 1.94% H: 2.38% C: 0.48%

health
Mark Borman appointed Chairman of the Board of USRM
Published: 2022-03-09 (Crawled : 14:30) - us-stemcell.com
USRM | $0.0001 1300.0% 290K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 0.0% H: 28.38% C: 12.16%

air
Embark Hires Senior Legislative Representative from Teamsters Union to Lead Federal Policy Effort
Published: 2022-03-09 (Crawled : 12:30) - globenewswire.com
EMBK | $2.88 0.35% 0.17% 0 twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 8.83% H: 0.0% C: 0.0%

mst
Design Therapeutics Announces Preclinical Data Highlighting Novel GeneTAC™ Therapy for the Treatment of Fuchs Endothelial Corneal Dystrophy to be Presented at ARVO 2022
Published: 2022-03-09 (Crawled : 12:00) - globenewswire.com
DSGN | $3.65 -0.27% -0.14% 100 twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 2.53% H: 12.75% C: 8.46%

treatment therapeutics preclinical therapy pre-clinical designation
Biomea Fusion Announces Upcoming Presentations of Preclinical Data in Diffuse Large B-Cell Lymphoma, Multiple Myeloma, and Several KRAS Mutant Solid Tumors for BMF-219 at AACR Annual Meeting 2022
Published: 2022-03-08 (Crawled : 00:00) - globenewswire.com
BMEA | $10.77 -1.91% -2.04% 140 twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 3.25% H: 4.04% C: 2.25%

bmf-219 solid tumors presentation cel preclinical t-cell pre-clinical
Gainers vs Losers
61% 39%

Top 10 Gainers
BOF | $2.08 77.78% 39.06% 110M twitter stocktwits trandingview |

BHIL | $0.1793 -4.37% 19.24% 340K twitter stocktwits trandingview |
Agriculture, Forestry, Fishing ...

UMAC | $1.48 -1.33% 14.87% 20K twitter stocktwits trandingview |

CI | $352.28 -0.11% 13.53% 2 twitter stocktwits trandingview |
Health Services

CIG.C | $2.89 -1.37% 12.8% 2.3K twitter stocktwits trandingview |
n/a

MTH | $154.69 -2.21% 12.68% 450K twitter stocktwits trandingview |
Consumer Durables

HCP | News | $31.41 7.75% 11.26% 1.2M twitter stocktwits trandingview |

BMTX 4 | $1.545 0.98% 10.03% 2.5K twitter stocktwits trandingview |
Information

TAL | $12.26 0.57% 9.22% 12M twitter stocktwits trandingview |
Consumer Services

ASXC | $0.243 -2.41% 7.0% 1.1M twitter stocktwits trandingview |
Manufacturing


Your saved searches
Save your searches and get alerts when important news are released.